According to Canadian medical technology trade group MEDEC, the new requirement will apply to all commercially reprocessed single-use devices, but Health Canada will leave in place provincial- and territorial-level oversight of device reprocessing, which is carried out at hospitals.
CMDR compliance includes Medical Device Licensing, quality system implementation and management, labeling, post market vigilance and other requirements that all other medical devices licensed for sale in Canada must meet. MEDEC touts Health Canada’s decision to fully regulate reprocessed devices as a positive step for public health, noting that a significant percentage of single-use devices in hospitals across the country are now reprocessed by third-party firms with no obligation to comply with CMDR.
Source: Emergo Group
Related Articles
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
-
The findings suggest that manufacturers need to make user interface and user experience design improvements to certain wearable medical devices.
-
The updated guidance clarifies how the program applies to medical devices that may address health inequities, as well as those that may increase access to care or provide a non-addictive treatment option to treat pain or addiction. It also clarifies…
-
Rapid developments in healthcare technology, combined with improved data collection, pandemic pressures and increased consumer demand for tech-enabled and virtual health care, are fueling innovation and transformation in the digital health space.
